is a drug
development company that sources late-stage discovery projects from
academia and spin-out companies, conducts early proof-of-principle
clinical studies and subsequently out-licenses the resulting programs
to the pharmaceutical and biotechnology industries.
Our team consists of experts in the fields of early drug
development, technology transfer and business development.